Pharmaceutical Company Darnitsa has been the leader in the sale of medicinal products by volume since 1998. The strategic directions of the product portfolio development of the company are cardiology, neurology and pain problems. Each 7 pack of medicines in pharmacy shelves is manufactured by Darnitsa.
The Company’s portfolio includes nearly 280 generic products in the Rx and OTC segments. We export products to 16 countries around the world having more than 400 registration abroad.